Sarah Cannon Research Institute-Nashville-48456 — Nashville, Tennessee

Sarah Cannon Research Institute-Nashville-48456 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute-Nashville-48456 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Solid Tumors, KRAS Mutation; SOS1, Neoplasm Metastasis, Non-Small Cell Lung Cancer.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute-Nashville-48456?

Sarah Cannon Research Institute-Nashville-48456 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute-Nashville-48456 conducted?

Sarah Cannon Research Institute-Nashville-48456 has 2 clinical trials on record, with 2 currently active. Their work covers Solid Tumors, KRAS Mutation; SOS1, Neoplasm Metastasis, Non-Small Cell Lung Cancer.

Is Sarah Cannon Research Institute-Nashville-48456 accredited by Crixeo Health?

Sarah Cannon Research Institute-Nashville-48456 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute-Nashville-48456?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.